Any rational evaluation of cannabis would dictate that should it be removed from the drug schedule. Now it appears that the Food and Drug Agency (FDA) is slowly starting to recognize the fallacy of cannabis (AKA Marijuana) being classified as a schedule 1 drug (definition of Schedule 1 is at the end of this article).
The FDA has now reopened the comment period on "International Drug Scheduling for Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis." Please take the time to take this additional time to submit comments to the FDA.
For more details and additional instructions see
https://www.regulations.gov/document?D=FDA_FRDOC_0001-9485
To comment please use the link below, note all comments are due Sep 30 2019, at 11:59 PM ET
https://www.regulations.gov/comment?D=FDA_FRDOC_0001-9485
All submissions received must include the Docket No. FDA-2019-N-0767 for “International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Dronabinol (delta-9 tetrahydrocannabinol) and its Stereoisomers; Cannabis, Cannabis Resin, Extracts and Tinctures; Cannabidiol Preparations; and Pharmaceutical Preparations of Cannabis.”
----------
The exact schedule 1 drug definition for marijuana per United States Law 21 U.S.C. ch. 13 § 801 signed by President Nixon in 1971 is listed below. Note Statements 1, 2, 3 are “LOGIC AND” legal statements.
1. There is a lack of accepted safety for use of the drug or other substance under medical supervision.
2. The drug or other substance has a high potential for abuse.
3. The drug or other substance has no currently accepted medical use in treatment in the United States.
